|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2003-3-4
|
|
pubmed:abstractText |
Asymptomatic, or "silent" atrial fibrillation could increase the risk of stroke. Little is known about the frequency of asymptomatic atrial fibrillation in patients who also have symptomatic atrial fibrillation; similarly, little is known about the effect of antiarrhythmic drug therapy on asymptomatic atrial fibrillation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1141-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12615792-Adult,
pubmed-meshheading:12615792-Anti-Arrhythmia Agents,
pubmed-meshheading:12615792-Atrial Fibrillation,
pubmed-meshheading:12615792-Dose-Response Relationship, Drug,
pubmed-meshheading:12615792-Double-Blind Method,
pubmed-meshheading:12615792-Electrocardiography,
pubmed-meshheading:12615792-Endpoint Determination,
pubmed-meshheading:12615792-Female,
pubmed-meshheading:12615792-Humans,
pubmed-meshheading:12615792-Imidazoles,
pubmed-meshheading:12615792-Imidazolidines,
pubmed-meshheading:12615792-Kinetics,
pubmed-meshheading:12615792-Male,
pubmed-meshheading:12615792-Middle Aged,
pubmed-meshheading:12615792-Piperazines,
pubmed-meshheading:12615792-Recurrence
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.
|
|
pubmed:affiliation |
Cardiovascular Division, Clinical Cardiac Electrophysiology, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, USA. rpage@u.washington.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
